Scholastic Corporation (SCHL) research: valuation against peers, fundamentals over time, risk and news coverage
SCHL
Scholastic CorporationNo data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTBEARISHInsider Selling Wave Broadens Across Mid-Cap America as Executives Cash Into Strength
A dense cluster of Form 4 disclosures spanning healthcare services, consumer retail, diagnostics, consumer durables and software points to coordinated executive de-risking into post-earnings rallies. Encompass Health saw three separate insiders sell after a rate increase, with the CFO cutting his direct common position 27% and CEO Mark Tarr trimming while retaining roughly 268,000 shares worth $33.7 million.
- BREAKING STORYNEUTRALQ2 Earnings Season Breaks Its Own Rules as Share-Price Reactions Decouple From Results
Analysts flag a widening disconnect between reported fundamentals and share-price reactions during a historic Q2 earnings season, complicating event-driven positioning. AbbVie's guidance for $12.7 billion in neuroscience sales this year is a case study in fundamentals the market has been slow to price.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.